Lung cancer
Conditions
Interventions
Sponsors
Shanghai Changhai Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Aged >= 18 years old; 2) clinically or pathologically diagnosed patients with stage I-IIIA lung cancer without any antineoplastic therapy before the first blood collection; 3) ECOG score 0 or 1; 4) subjects and family members can understand the study plan and are willing to participate in this study and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1) inflammatory reaction was caused by acute and severe diseases in the near future (14 days before blood sampling). Or have used hormone therapy within 14 days before drawing blood; 2) have a history of other tumor diseases or other hereditary diseases; 3) have received organ transplant, stem cell transplant, bone marrow transplant or blood transfusion in the past 1 month; 4) pregnant women; 5) have been participating in other clinical trials requiring medication (including intestinal preparation, anesthesia, etc.) within the last 60 days. 6) severe cardiovascular disease, uncontrollable infection, or other uncontrollable concomitant diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ctDNA;SEN, SPE, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactJinHai
Department of Thoracic Surgery, Changhai Hospital
Outcome results
None listed